Literature DB >> 25206993

Effects of Luteolin on Liver, Kidney and Brain in Pentylentetrazol-Induced Seizures: Involvement of Metalloproteinases and NOS Activities.

Hüsniye Birman1, Kadriye Akgün Dar2, Ayşegül Kapucu2, Samet Acar2, Gülay Uzüm1.   

Abstract

OBJECTIVE: Flavonoids are an important group of recognized antioxidants in plants. Luteolin (LUT) is a natural flavonoid in the plant kingdom. This study was aimed to investigate the effects of the LUT in the liver, kidney and brain of pentylentetrazol (PTZ)-induced seizure and the relationship between nitric oxide synthases (iNOS, eNOS) and matrix metalloproteinases (MMP2, MMP9).
MATERIALS AND METHODS: LUT (10 mg/kg) was given intraperitoneally during two weeks prior to seizure induction. A single dose PTZ 80 mg/kg i.p. was administered and seizures were observed and evaluated with regard to latency, frequency and stage for one hour.
RESULTS: Seizure frequen cy after PTZ administration was significantly decreased in LUT pretreated rats (p<0.05). An increase of immunhistochemical reactions of iNOS and MMP2, but a decrease of eNOS activity, were observed in rat hippocampus and peripheral tissues during the PTZ induced seizures. LUT pretreatment reversed the iNOS and MMP2 activity to the control levels and significantly increased the eNOS activity (p<0.001).
CONCLUSION: LUT seems to have an effective role in reducing the seizure frequency and a protective role on peripheral organ injury in animal models of seizure. The protective effect of LUT in seizures and the seizure induced peripheral tissue damage warrant further investigations.

Entities:  

Keywords:  Luteolin; NOS; metalloproteinases; pentylentetrazol; seizure

Year:  2012        PMID: 25206993      PMCID: PMC4115855          DOI: 10.5152/balkanmedj.2011.030

Source DB:  PubMed          Journal:  Balkan Med J        ISSN: 2146-3123            Impact factor:   2.021


  38 in total

1.  Neuroprotective effects of flavones on hydrogen peroxide-induced apoptosis in SH-SY5Y neuroblostoma cells.

Authors:  Sam Sik Kang; Ji Yeon Lee; Yoo Keum Choi; Gap Seok Kim; Byung Hee Han
Journal:  Bioorg Med Chem Lett       Date:  2004-05-03       Impact factor: 2.823

Review 2.  Matrix metalloproteinases (MMPs) in health and disease: an overview.

Authors:  Charles J Malemud
Journal:  Front Biosci       Date:  2006-05-01

3.  Tea catechins attenuate chronic ventricular remodeling after myocardial ischemia in rats.

Authors:  Jun-ichi Suzuki; Masahito Ogawa; Yasuhiro Maejima; Kazuya Isobe; Hiroyuki Tanaka; Yuko M Sagesaka; Mitsuaki Isobe
Journal:  J Mol Cell Cardiol       Date:  2006-12-15       Impact factor: 5.000

Review 4.  Optimizing therapy of seizures in patients with renal or hepatic dysfunction.

Authors:  Glenda Lacerda; Thierry Krummel; Cécile Sabourdy; Philippe Ryvlin; Edouard Hirsch
Journal:  Neurology       Date:  2006-12-26       Impact factor: 9.910

Review 5.  Microglial secretion products and their impact on the nervous system.

Authors:  D Giulian; M Corpuz
Journal:  Adv Neurol       Date:  1993

6.  Anticonvulsant effects of cyclosporin A on pentylenetetrazole-induced seizure and kindling: modulation by nitricoxidergic system.

Authors:  Houman Homayoun; Simin Khavandgar; Ahmad Reza Dehpour
Journal:  Brain Res       Date:  2002-06-07       Impact factor: 3.252

7.  Neuronal activity-dependent increase of net matrix metalloproteinase activity is associated with MMP-9 neurotoxicity after kainate.

Authors:  Jérôme Jourquin; Evelyne Tremblay; Nadège Décanis; Gérard Charton; Stephen Hanessian; Anne-Marie Chollet; Thierry Le Diguardher; Michel Khrestchatisky; Santiago Rivera
Journal:  Eur J Neurosci       Date:  2003-09       Impact factor: 3.386

8.  Quercetin inhibition of tumor invasion via suppressing PKC delta/ERK/AP-1-dependent matrix metalloproteinase-9 activation in breast carcinoma cells.

Authors:  Cheng-Wei Lin; Wen-Chi Hou; Shing-Chuan Shen; Shu-Hui Juan; Ching-Huai Ko; Ling-Mei Wang; Yen-Chou Chen
Journal:  Carcinogenesis       Date:  2008-07-14       Impact factor: 4.944

Review 9.  Update on uses and properties of citrus flavonoids: new findings in anticancer, cardiovascular, and anti-inflammatory activity.

Authors:  O Benavente-García; J Castillo
Journal:  J Agric Food Chem       Date:  2008-07-02       Impact factor: 5.279

10.  Flavonoids and nitric oxide synthase.

Authors:  R Olszanecki; A Gebska; V I Kozlovski; R J Gryglewski
Journal:  J Physiol Pharmacol       Date:  2002-12       Impact factor: 3.011

View more
  5 in total

Review 1.  The Flavone Luteolin Improves Central Nervous System Disorders by Different Mechanisms: A Review.

Authors:  Zeinab Ashaari; Mousa-Al-Reza Hadjzadeh; Gholamreza Hassanzadeh; Tahereh Alizamir; Behpour Yousefi; Zakieh Keshavarzi; Tahmineh Mokhtari
Journal:  J Mol Neurosci       Date:  2018-08-06       Impact factor: 3.444

Review 2.  The role of flavonoids on oxidative stress in epilepsy.

Authors:  Tâmara Coimbra Diniz; Juliane Cabral Silva; Sarah Raquel Gomes de Lima-Saraiva; Fernanda Pires Rodrigues de Almeida Ribeiro; Alessandra Gomes Marques Pacheco; Rivelilson Mendes de Freitas; Lucindo José Quintans-Júnior; Jullyana de Souza Siqueira Quintans; Rosemairy Luciane Mendes; Jackson Roberto Guedes da Silva Almeida
Journal:  Oxid Med Cell Longev       Date:  2015-01-11       Impact factor: 6.543

Review 3.  Paving Luteolin Therapeutic Potentialities and Agro-Food-Pharma Applications: Emphasis on In Vivo Pharmacological Effects and Bioavailability Traits.

Authors:  Yasaman Taheri; Javad Sharifi-Rad; Gizem Antika; Yakup Berkay Yılmaz; Tugba Boyunegmez Tumer; Sawsan Abuhamdah; Subhash Chandra; Sarla Saklani; Ceyda Sibel Kılıç; Simona Sestito; Sevgi Durna Daştan; Manoj Kumar; Mohammed M Alshehri; Simona Rapposelli; Natália Cruz-Martins; William C Cho
Journal:  Oxid Med Cell Longev       Date:  2021-09-20       Impact factor: 6.543

Review 4.  Pharmacological effects and therapeutic potential of natural compounds in neuropsychiatric disorders: An update.

Authors:  Parina Asgharian; Cristina Quispe; Jesús Herrera-Bravo; Mahsa Sabernavaei; Kamran Hosseini; Haleh Forouhandeh; Tahereh Ebrahimi; Paria Sharafi-Badr; Vahideh Tarhriz; Saiedeh Razi Soofiyani; Paweł Helon; Jovana Rajkovic; Sevgi Durna Daştan; Anca Oana Docea; Javad Sharifi-Rad; Daniela Calina; Wojciech Koch; William C Cho
Journal:  Front Pharmacol       Date:  2022-09-15       Impact factor: 5.988

5.  Inhibition of microglia overactivation restores neuronal survival in a mouse model of CDKL5 deficiency disorder.

Authors:  Giuseppe Galvani; Nicola Mottolese; Laura Gennaccaro; Manuela Loi; Giorgio Medici; Marianna Tassinari; Claudia Fuchs; Elisabetta Ciani; Stefania Trazzi
Journal:  J Neuroinflammation       Date:  2021-07-08       Impact factor: 8.322

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.